[The results of the adjuvant chemotherapy of patients with small-cell lung cancer].
The effectiveness of treatment (surgery; surgery + chemotherapy) was compared in a group of 122 patients with small-cell lung cancer. Median survival after postoperative chemotherapy rose from 40.9 to 81.8 weeks. However, five-year survival was nearly identical--8.1% (surgery) and 10.0% (surgery + chemotherapy).
Grants
E A
EA
Berzinia
V Iu
VIu
Bashko
Ia Ia
IaIa
Zitare
I Ia
IIa
Berzin'sh
Iu A
IuA
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000401:mortality; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011013:Pneumonectomy; D011182:Postoperative Care
Rezul'taty ad''iuvantnoĭ khimioterapii bol'nykh melkokletochnym rakom legkogo.